Gu X, Kay E P
Doheny Eye Institute, Los Angeles, CA 90033, USA.
Invest Ophthalmol Vis Sci. 1998 Nov;39(12):2252-8.
Corneal endothelial modulation factor (CEMF) released by inflammatory cells induces de novo synthesis of fibroblast growth factor (FGF)-2, which is a morphogen and a potent mitogen of corneal endothelial cells (CECs). Four isoforms of FGF-2 have been found in the nucleus, cytoplasm, or extracellular matrix (ECM) in different cell lines. In the present study, the profiles of the isoforms of FGF-2 that are induced by CEMF were investigated, and whether the differential localization of the isoforms of FGF-2 plays a role in CECs proliferation and subsequent modulation was examined.
Nuclear, cytoplasmic, and ECM fractions of normal and modulated CECs were separated, and FGF-2 isoforms were further purified by heparin-Sepharose column. The molecular sizes of the isoforms were determined by immunoblot analysis, using a specific antibody directed against FGF-2. Cell proliferation was determined by cell counting. Cellular localization of FGF-2 was determined by immunofluorescence staining during different stages of cell growth.
To confirm that CEMF modulated CECs under the conditions used in this study, its effect on cell proliferation and cell shape was determined: CEMF-treated cells showed enhanced cell proliferation profiles and fibroblastlike morphology. In rapidly growing normal CECs, FGF-2 was predominantly present in the nucleus. As the cells reached confluence, the staining potential in the nucleus was markedly reduced. Cytoplasmic staining of FGF-2 was barely detectable, regardless of cell stages. In CEMF-modulated cells, the rapidly growing cells showed strong staining of FGF-2 in the nucleus, whereas cytoplasmic and ECM staining was weak. When modulated cells reached confluence, the staining of FGF-2 in the nuclei remained strong, whereas ECM staining was significantly increased. Immunoblot analysis of the subcellular fraction showed that the 24-kDa FGF-2 was predominantly present in the nucleus, whereas the 18-kDa form was the major molecule in cytoplasmic and ECM fractions in normal and modulated cells.
These findings indicate that 24-kDa nuclear FGF-2 may be involved in cell proliferation in growing CECs. The persistent nuclear localization and simultaneous ECM localization of FGF-2 are induced by CEMF, and these FGF-2 isoforms seem to play a role in cell proliferation and modulation.
炎症细胞释放的角膜内皮调节因子(CEMF)可诱导成纤维细胞生长因子(FGF)-2的从头合成,FGF-2是一种形态发生素,也是角膜内皮细胞(CEC)的强效促有丝分裂原。在不同细胞系的细胞核、细胞质或细胞外基质(ECM)中已发现FGF-2的四种异构体。在本研究中,研究了由CEMF诱导的FGF-2异构体的分布情况,并检测了FGF-2异构体的差异定位是否在CEC增殖及后续调节中发挥作用。
分离正常和经调节的CEC的细胞核、细胞质和ECM组分,通过肝素-琼脂糖柱进一步纯化FGF-2异构体。使用针对FGF-2的特异性抗体,通过免疫印迹分析确定异构体的分子大小。通过细胞计数确定细胞增殖情况。在细胞生长的不同阶段,通过免疫荧光染色确定FGF-2的细胞定位。
为了证实在本研究使用的条件下CEMF对CEC有调节作用,测定了其对细胞增殖和细胞形态的影响:经CEMF处理的细胞显示出增强的细胞增殖情况和成纤维细胞样形态。在快速生长的正常CEC中,FGF-2主要存在于细胞核中。当细胞达到汇合状态时,细胞核中的染色强度明显降低。无论细胞处于何种阶段,FGF-2的细胞质染色几乎检测不到。在经CEMF调节的细胞中,快速生长的细胞在细胞核中显示出强烈的FGF-2染色,而细胞质和ECM染色较弱。当调节后的细胞达到汇合状态时,细胞核中FGF-2的染色仍然很强,而ECM染色显著增加。亚细胞组分的免疫印迹分析表明,24 kDa的FGF-2主要存在于细胞核中,而18 kDa的形式是正常和调节细胞中细胞质和ECM组分中的主要分子。
这些发现表明,24 kDa的细胞核FGF-2可能参与生长中的CEC的细胞增殖。CEMF诱导FGF-2持续的细胞核定位和同时的ECM定位,这些FGF-2异构体似乎在细胞增殖和调节中发挥作用。